Maeve Sheehan, M.D.
Dr. Sheehan is a graduate of the University College Dublin, Medical School, Ireland. She undertook further training in Ireland, including a Higher Diploma in Child Health, and then completed a three year Residency Program in Pediatric and Adolescent Medicine at the Cleveland Clinic, Cleveland, Ohio. Dr Sheehan completed Fellowship training in Pediatric Critical Care at Cincinnati Children’s Hospital, Cincinnati, Ohio. Dr Sheehan’s research interests include shock, patient safety and transportation of critically ill children. Dr Sheehan is an Associate Professor in the Department of Pediatrics at UT Medical Center and Childrens Medical Center, Dallas, Texas. Dr Sheehan's administrative roles include Medical Directorship of Transport, Access and Inpatient services at Children's Medical Center.
|Medical School||The University of Ireland (1993)|
|Internship||St. Vincents Hospital - Dublin Ireland (1994), Surgery|
|Residency||Boston Medical Center - GME (1994), Internal Medicine|
|Residency||The Children's Hospital-Dublin, Ireland (1995), Pediatrics|
|Residency||The National Maternity Hospital-Dublin, Ireland (1995), Neonatal-perinatal Medicine|
|Residency||Cleveland Clinic Foundation (1999), Pediatrics|
|Fellowship||Children's Hospital Medical Center (2002), Pediatric Critical Care Medicine|
Perixosome proliferators activator receptor - &gamma ligands, 15-deoxy - &Delta-; 12, 14- prostaglandin J2 and ciglitizone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways.
B. Zingarelli, M. Sheehan, P. W. Hake, M. O? Connor, A. Denenberg, J. Cook. J Immunol December 2003 15;171(12) 6827-37
Nuclear factor-KB as a therapeutic target in critical care medicine
H. R. Wong, M. Sheehan, B. Zingarelli Critical Care Medicine 2003 31, no. 1
Protective effects of isohelenin, an inhibitor of nuclear factor -KB, in endotoxic shock in rats
M. Sheehan,H.R. Wong, P. W. Hake, B. Zingarelli Journal of Endotoxin Research 2002 8 99-107
Yet another potential role for nitric oxide in the pathophysiology of septic shock
M. Sheehan, H. R. Wong Crit Care Med 2002 Vol. 30, No 6
Parthenolide, an inhibitor of the nuclear factor-KB pathway, ameliorates cardiovascular derangement and outcome in endotoxic shock in rodents.
M. Sheehan, H.R. Wong, P. W. Hake, V. Malhotra, M. O' Connor, B. Zingarelli Molecular Pharmacology 2002 61 953-963